Literature DB >> 9080358

Excessive circadian amplitude of blood pressure increases risk of ischaemic stroke and nephropathy.

K Otsuka1, G Cornélissen, F Halberg, G Oehlerts.   

Abstract

After 48-h ambulatory blood pressure monitoring, the incidence of ischaemic stroke, nephropathy, coronary heart disease and retinopathy was prospectively assessed for 6 years in 297 subjects, including 176 treated patients with an elevated blood pressure mean (MESOR-hypertensives). The relative risk associated with an excessive circadian blood pressure amplitude is 8.2 (95% confidence interval 3.1 to 21.7; p < 0.001) for ischaemic stroke and 6.9 (2.9 to 16.3; p < 0.001) for nephropathy. In MESOR-hypertensives, the relative risk for ischaemic stroke and nephropathy is 6.3 (p < 0.005) and 4.0 (p < 0.05), respectively. In MESOR-normotensives as well, an excessive circadian blood pressure amplitude is associated with a large increase in risk for ischaemic stroke and nephropathy (p < 0.05). An excessive circadian blood pressure amplitude is an entity in its own right that increases the risk of adverse vascular events irrespective of the blood pressure MESOR, age and the presence of other known risk factors. The diagnosis of this condition requires around-the-clock monitoring of blood pressure. The treatment of patients with this condition should aim not only at lowering the blood pressure mean but also at reducing blood pressure variability within 24 h.

Entities:  

Mesh:

Year:  1997        PMID: 9080358     DOI: 10.3109/03091909709030299

Source DB:  PubMed          Journal:  J Med Eng Technol        ISSN: 0309-1902


  12 in total

1.  Chronobiology predicts actual and proxy outcomes when dipping fails.

Authors:  Germaine Cornélissen; Franz Halberg; Kuniaki Otsuka; R B Singh; Chen-Huan Chen
Journal:  Hypertension       Date:  2006-10-30       Impact factor: 10.190

Review 2.  Schedule shifts, cancer and longevity: good, bad or indifferent?

Authors:  Germaine Cornélissen; Julia Halberg; Franz Halberg; Salvador Sanchez de la Pena; Walter Nelson; Othild Schwartzkopff; Alexander Stoynev; Erhard Haus
Journal:  J Exp Ther Oncol       Date:  2008

3.  Plasma catecholamines: follow-up on 10-year study in health and cardiovascular disease.

Authors:  P Prikryl; G Cornélissen; K Otsuka; F Halberg
Journal:  Biomed Pharmacother       Date:  2005-10       Impact factor: 6.529

4.  Circadian rhythm of maternal blood pressure and fetal growth.

Authors:  C Maggioni; G Cornélissen; K Otsuka; F Halberg; D Consonni; U Nicolini
Journal:  Biomed Pharmacother       Date:  2005-10       Impact factor: 6.529

5.  Opportunity of detecting pre-hypertension: worldwide data on blood pressure overswinging.

Authors:  G Cornélissen; A Delcourt; G Toussaint; K Otsuka; Y Watanabe; J Siegelova; B Fiser; J Dusek; P Homolka; R B Singh; A Kumar; R K Singh; S Sanchez; C Gonzalez; D Holley; B Sundaram; Z Zhao; B Tomlinson; B Fok; M Zeman; K Dulkova; Franz Halberg
Journal:  Biomed Pharmacother       Date:  2005-10       Impact factor: 6.529

6.  Circadian and circaseptan (about-weekly) aspects of immigrant Indians' blood pressure and heart rate in California, USA.

Authors:  B Sundaram; D C Holley; G Cornélissen; D Naik; R Hanumansetty; R B Singh; K Otsuka; F Halberg
Journal:  Biomed Pharmacother       Date:  2005-10       Impact factor: 6.529

7.  Chronobiologically explored effects of Telmisartan.

Authors:  Pavel Prikryl; Germaine Cornélissen; Jiri Neubauer; Pavel Prikryl; Zdenek Karpisek; Yoshihiko Watanabe; Kuniaki Otsuka; Franz Halberg
Journal:  Clin Exp Hypertens       Date:  2005 Feb-Apr       Impact factor: 1.749

8.  Abnormalities in circadian blood pressure variability and endothelial function: pragmatic markers for adverse cardiometabolic profiles in asymptomatic obese adults.

Authors:  Alok K Gupta; Germaine Cornelissen; Frank L Greenway; Vijay Dhoopati; Franz Halberg; William D Johnson
Journal:  Cardiovasc Diabetol       Date:  2010-09-24       Impact factor: 9.951

9.  Nighttime blood pressure dipping in young adults and coronary artery calcium 10-15 years later: the coronary artery risk development in young adults study.

Authors:  Anthony J Viera; Feng-Chang Lin; Alan L Hinderliter; Daichi Shimbo; Sharina D Person; Mark J Pletcher; David R Jacobs
Journal:  Hypertension       Date:  2012-04-30       Impact factor: 10.190

Review 10.  Diagnosing vascular variability anomalies, not only MESOR-hypertension.

Authors:  Franz Halberg; Deborah Powell; Kuniaki Otsuka; Yoshihiko Watanabe; Larry A Beaty; Paul Rosch; Jerzy Czaplicki; Dewayne Hillman; Othild Schwartzkopff; Germaine Cornelissen
Journal:  Am J Physiol Heart Circ Physiol       Date:  2013-05-24       Impact factor: 4.733

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.